Skip to content

Category: Top Stories

Nvidia to rally more than 30% as dealmaking ramps up, Barclays says

Business Men Break Sit Read Newspaper

The investment bank, which has an overweight rating on shares, raised its price target on Nvidia.

European Commission launches antitrust probe into software giant SAP

Business Men Break Sit Read Newspaper

SAP said it did not expect the investigation to have a material impact on its bottom line.

Walmart teams up with Spain’s La Liga, furthering the retailer’s investment in soccer

Business Men Break Sit Read Newspaper

Walmart is doubling down on its investment in soccer ahead of the 2026 FIFA World Cup across the U.S., Mexico and Canada.

New York City mayor candidate Curtis Sliwa says he was offered money to quit race

Business Men Break Sit Read Newspaper

President Trump has suggested that Curtis Sliwa and Mayor Eric Adams drop out as candidates to allow a showdown between Zohran Mamdani and Andrew Cuomo.

U.S. Latino immigrants generate $1.6 trillion in GDP, report says

Business Men Break Sit Read Newspaper

Mass deportations of undocumented workers could cause GDP to decline by $2.3 trillion, or 7.7%, in 2025 dollars, according to the report.

H&M shares jump 10% on third-quarter sales beat as turnaround takes pace

Business Men Break Sit Read Newspaper

The retailer is undergoing a turnaround strategy under CEO Daniel Erver.

Bank stocks could benefit from Fed rate cuts. These dividend-payers are Wall Street’s favorites

Business Men Break Sit Read Newspaper

A recent analysis by Wells Fargo found that when the Fed cuts rates and there is no recession, bank stocks have historically rallied. Many names pay dividends.

European stocks poised for mixed open ahead of U.S. jobs data

Business Men Break Sit Read Newspaper

Shares listed in Europe look set for a muted open on Thursday.

Early Revolut backer invests in AI-focused finance software startup Light

Business Men Break Sit Read Newspaper

Danish startup Light wants to disrupt the decades-old world of corporate accounting software.

Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial

Business Men Break Sit Read Newspaper

Roche Pharmaceuticals’ CEO told investors she was “serious” about the goal of becoming a top 3 obesity player.

← Previous
Next →

Ready to take your stock trading to the next level? Sign up now to receive exclusive market analyses, insightful tips, and valuable resources straight to your inbox. Don’t miss out on the opportunity to stay ahead in the ever-evolving world of trading!

JOIN OUR COMMUNITY

Join our growing community of educated investors working together to build wealth with a diversified outlook at investment opportunities

Copyright © 2023. All Rights Reserved.

  • Privacy & Policy
  • Disclaimer